| Original language | English |
|---|---|
| Number of pages | 0 |
| Journal | Multiple Sclerosis and Related Disorders |
| Volume | 63 |
| Issue number | 0 |
| Early online date | 27 May 2022 |
| DOIs | |
| Publication status | Published - Jul 2022 |
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
- Ruth Dobson*
- , Matthew Craner
- , Ed Waddingham
- , Aleisha Miller
- , Jayant Pindoria
- , Ana Cavey
- , Camilla Blain
- , Luca G De
- , Nikos Evangelou
- , Helen Ford
- , Paul Gallagher
- , Katila George
- , Ramos Dias R Geraldes
- , Paula Harman
- , Jeremy Hobart
- , Tanya King
- , Ruth Linighan
- , Niall MacDougall
- , Monica Marta
- , Stephanie Mitchell
*Corresponding author for this work
- Queen Mary University of London
- Royal London Hospital
- Frimley Health NHS Foundation Trust
- John Radcliffe Hospital
- Imperial College London
- St George's Hospital
- Nottingham University Hospitals NHS Trust
- Leeds Teaching Hospitals NHS Trust
- Queen Elizabeth University Hospital, Glasgow
- Southend Hospital
- University Hospitals Plymouth NHS Trust
- Institute of Neurological Sciences
- NHS Lanarkshire
- Northern Care Alliance NHS Group
- Charing Cross Hospital
- Southmead Hospital NHS Trust
- University of Bristol
- The Walton Centre NHS Foundation Trust
Research output: Contribution to journal › Article › peer-review
20
Downloads
(Pure)